Actually, CG-806 demonstrates much higher anti-AURK activity than midostaurin (IC50s are 3 nM vs. 300 nM, respectively in CG-806 vs. midostaurin) (49), suggesting a more potent against AML with FLT3-WT. This evidence concerns the gene FLT3 and acute myeloid leukemia.